Today’s sharp thought: AI hallucinations are a function of product quality obsession

Source: Nate’s Newsletter Date: 2024-10-07 URL: https://natesnewsletter.substack.com/p/todays-sharp-thought-ai-hallucinations

Summary

Nate argues AI hallucinations aren’t inevitable technical failures — they’re consequences of insufficient product quality obsession. Using CaseText’s $650M acquisition by Thomson Reuters as proof, the argument is that “painfully specific micro-evals” in narrow domains can systematically reduce hallucinations to the point where reliability commands significant market value. Domain-specific quality engineering beats general-purpose capability chasing.

Implications

• Agent-product positioning thread. Micro-evals as the hallucination solution is a concrete product methodology: narrow the domain, define exacting quality metrics, iterate against them obsessively. This is how legal AI (CaseText), medical AI, and other high-stakes verticals will beat horizontal AI platforms on reliability.
• AI economics thread. The CaseText $650M acquisition validates that domain-specific reliability is a premium market position. Organizations building narrow, high-reliability AI products in vertical markets have clearer monetization paths than those building broad, general-purpose tools.
• Watch: Which vertical domains develop the strongest micro-eval cultures and build the most reliable AI products — these are the acquisition targets for enterprise software incumbents and AI platforms seeking vertical depth.